Abstract：Objective To study the three biomarkers of L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are used to predict the prognosis of children patients with kawasaki disease (KD). Methods From January 2012 to December 2013, 39 children with KD in Department of Pediatric in Taihe Hospital were selected as the case group, venous blood was collected, and at the same time, the plasma of 27 children patients matched with age was collected as control group, which of respiratory infection was accompanied by fever and exclusion of involvement of myocardium. The plasma levels of L-arginine, ADMA and SDMA were measured in the case group and control group. Results The plasma levels of L-arginine, ADMA and SDMA before intravenous immunoglobulin (IVIG) treatment of children in the case group KD1 were lower than those of control group (P < 0.05 or P < 0.01). After IVIG treatment, the L-arginine, ADMA, L-arginine/ADMA ratio (AAR) and arginine methylation composite index (AMI) of different treatment time in case group were compared, the differences were highly statistically significant (P < 0.01). The plasma levels of SDMA of children in case group KD1, case group KD2, case group KD3, case group KD4 were all lower than the control group (P < 0.01), but comparison of before and after IVIG treatment, the difference were not statistically significant (P > 0.05). The AMDA/SMDA ratio (ASR) of children in case group KD2, case group KD3, case group KD4 were all higher than control group and case group KD1 (P < 0.01). In the case group KD1, the L-arginine level of children with coronary artery dilation was higher than that in children without coronary artery dilatation (P < 0.01), while in the case group KD2 and the case group KD3, the children patients with coronary artery dilation was lower than that in children without coronary artery dilatation (P < 0.01). Conclusion The levels of L-arginine, ADMA and SDMA may be related to KD. Low level of L-arginine and ASR of after IVIG treatment are associated with children patients with abnormal coronary artery KD.
李显东 吕军 胡秀学. 不对称和对称二甲基精氨酸与川崎病冠状动脉病变相关性分析[J]. 中国医药导报, 2018, 15(11): 63-66.
LI Xiandong LV Jun HU Xiuxue . Correlation analysis between asymmetric dimethylarginine and symmetric dimethylarginine and coronary artery disease of kawasaki disease. 中国医药导报, 2018, 15(11): 63-66.
[1] Kuo HC，Wang CL，Liang CD，et al. Association of lower eosinophil-related T helper 2（Th2）cytokines with coronary artery lesions in Kawasaki disease [J]. Pediatr Allergy Immunol，2009，20（3）：266-272.
[2] Yamakawa R，Ishii M，Sugimura T，et al. Coronary endothelial dysfunction after Kawasaki disease：evaluation by intracoronary injection of acetylcholine [J]. J Am Coll Cardiol，1998，31（5）：1074-1080.
[3] Tain YL，Freshour G，Dikalova A，et al. Vitamin E reduces glomerulosclerosis，restores renal neuronal NOS，and suppresses oxidative stress in the 5/6 nephrectomized rat [J]. Am J Physiol Renal Physiol，2007，292（5）：F1404.
[4] Wang CL，Wu YT，Lee CJ，et al. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease [J]. J Pediatr，2002，141（4）：560-565.
[5] Teerlink T，Luo Z，Palm F，et al. Cellular ADMA：regulation and action [J]. Pharmacol Res，2009，60（6）：448-460.
[6] Tain YL，Huang LT. Asymmetric dimethylarginine：clinical applications in pediatric medicine [J]. J Formos Med Assoc，2011，110（2）：70.
[7] Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [J]. Cardiovasc Res，2003，59（4）：824-833.
[8] Newburger JW，Takahashi M，Gerber MA，et al. Diagnosis，treatment，and long-term management of Kawasaki disease：a statement for health professionals from the committee on rheumatic fever，endocarditis and Kawasaki disease，council on cardiovascular disease in the young，Ame?rican heart association [J]. Circulation，2004，110（17）：2747-2771.
[9] 黄铮.美国心脏病学会（AHA）川崎病诊断指南[J].岭南心血管病杂志，2003，（4）：301.
[10] Matsubara T，Mason W，Kashani IA，et al. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease [J]. J Pediatr，1996，28（5）：701-703.
[11] Xie T，Wang Y，Fu S，et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease [J]. Pediatr Rheumatol Online J，2017，15（1）：17.
[12] Kuo HC，Yang KD，Liang CD，et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease [J]. Pediatr Allergy Immunol，2007，18（4）：354-359.
[13] Huang LT，Chen CC，Sheen JM，et al. The interaction between high ammonia diet and bile duct ligation in developing rats：assessment by spatial memory and asymmetric dimethylarginine [J]. Int J Dev Neurosci，2010，28（2）：169-174.
[14] Oakley F，Trim N，Constandinou CM，et al. Hepatocytes express nerve growth factor during liver injury：evidence for paracrine regulation of hepatic stellate cell apoptosis [J]. Am J Pathol，2003，163（5）：1849-1858.
[15] Bouras G，Deftereos S，Tousoulis D，et al. Asymmetric Dimethylarginine（ADMA）：a promising biomarker for cardiovascular disease [J]. Curr Top Med Chem，2013，13（2）：180-200.
[16] Straface E，Gambardella L，Metere A，et al. Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease [J]. Biochem Biophys Res Commun，2010， 392（3）：426-430.
[17] Eleuteri E，Magno F，Gnemmi I，et al. Role of oxidative and nitrosative stress biomarkers in chronic heart failure [J]. Front Biosci（Landmark Ed），2009，14：2230.
[18] Tojo A，Welch WJ，Bremer V，et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney [J]. Kidney Int，1997，52（6）：1593-1601.
[19] Ikemoto Y，Teraguchi M，Ono A，et al. Serial changes of plasma nitrate in the acute phase of Kawasaki disease [J]. Pediatr Int，2003，45（4）：421-425.
[20] Dhillon R，Clarkson P，Donald AE，et al. Endothelial dysfunction late after Kawasaki disease [J]. Circulation，1996， 94（9）：2103-2106.
2018, Vol. 15 
京公网安备 11010502046598号